These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 9170090)

  • 1. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia.
    Scott-Moncrieff JC; Reagan WJ; Snyder PW; Glickman LT
    J Am Vet Med Assoc; 1997 Jun; 210(11):1623-7. PubMed ID: 9170090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia.
    Whelan MF; O'Toole TE; Chan DL; Rozanski EA; DeLaforcade AM; Crawford SL; Cotter SM
    J Vet Emerg Crit Care (San Antonio); 2009 Apr; 19(2):158-64. PubMed ID: 19691566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of human intravenous immunoglobulin in dogs with primary immune mediated hemolytic anemia].
    Gerber B; Steger A; Hässig M; Glaus TM
    Schweiz Arch Tierheilkd; 2002 Apr; 144(4):180-5. PubMed ID: 12038216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990).
    Klag AR; Giger U; Shofer FS
    J Am Vet Med Assoc; 1993 Mar; 202(5):783-8. PubMed ID: 8454517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-mediated hemolytic anemia and severe thrombocytopenia in dogs: 12 cases (2001-2008).
    Orcutt ES; Lee JA; Bianco D
    J Vet Emerg Crit Care (San Antonio); 2010 Jun; 20(3):338-45. PubMed ID: 20636987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
    Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E
    J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulin.
    Spurlock NK; Prittie JE
    J Vet Emerg Crit Care (San Antonio); 2011 Oct; 21(5):471-83. PubMed ID: 22316195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine immune-mediated hemolytic anemia: pathophysiology, clinical signs, and diagnosis.
    Balch A; Mackin A
    Compend Contin Educ Vet; 2007 Apr; 29(4):217-25. PubMed ID: 17726851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenectomy as an adjunctive treatment for dogs with immune-mediated hemolytic anemia: ten cases (2003-2006).
    Horgan JE; Roberts BK; Schermerhorn T
    J Vet Emerg Crit Care (San Antonio); 2009 Jun; 19(3):254-61. PubMed ID: 19691510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-mediated hemolytic anemia: 70 cases (1988-1996).
    Reimer ME; Troy GC; Warnick LD
    J Am Anim Hosp Assoc; 1999; 35(5):384-91. PubMed ID: 10493413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of different prognostic markers in dogs with primary immune-mediated hemolytic anemia].
    Griebsch C; Arndt G; Kohn B
    Berl Munch Tierarztl Wochenschr; 2010; 123(3-4):160-8. PubMed ID: 20329649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human intravenous immunoglobulin therapy.
    Scott-Moncrieff JC; Reagan WJ
    Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):178-85. PubMed ID: 9283243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine immune-mediated hemolytic anemia: treatment and prognosis.
    Balch A; Mackin A
    Compend Contin Educ Vet; 2007 Apr; 29(4):230-8; quiz 239. PubMed ID: 17726852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982-1987).
    Klein MK; Dow SW; Rosychuk RA
    J Am Vet Med Assoc; 1989 Jul; 195(2):246-50. PubMed ID: 2768046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of nonregenerative anemia with human gamma-globulin in dogs.
    Scott-Moncrieff JC; Reagan WJ; Glickman LT; DeNicola DB; Harrington D
    J Am Vet Med Assoc; 1995 Jun; 206(12):1895-900. PubMed ID: 7540607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of blood lactate concentration with outcome in dogs with idiopathic immune-mediated hemolytic anemia: 173 cases (2003-2006).
    Holahan ML; Brown AJ; Drobatz KJ
    J Vet Emerg Crit Care (San Antonio); 2010 Aug; 20(4):413-20. PubMed ID: 20731807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive therapy for canine immune-mediated hemolytic anemia.
    Al-Ghazlat S
    Compend Contin Educ Vet; 2009 Jan; 31(1):33-41, 44; quiz 44. PubMed ID: 19241356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-mediated haemolytic anaemia in 110 dogs in Victoria, Australia.
    McAlees TJ
    Aust Vet J; 2010 Jan; 88(1-2):25-8. PubMed ID: 20148823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs.
    West LD; Hart JR
    J Vet Emerg Crit Care (San Antonio); 2014; 24(2):226-31. PubMed ID: 24251650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenectomy as adjunctive therapy for immune-mediated thrombocytopenia and hemolytic anemia in the dog.
    Feldman BF; Handagama P; Lubberink AA
    J Am Vet Med Assoc; 1985 Sep; 187(6):617-9. PubMed ID: 4086369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.